FDA gives Varian Medical nod on 2 cancer therapy systems

01/25/2013 | RTT News

The FDA has given Varian Medical Systems 510(k) clearance for a new version of the company's Vitesse system, which allows doctors to plan high-dose-rate brachytherapy for prostate cancer patients in real time. The FDA also has cleared the company's Edge radiosurgery system, which comes with motion management and real-time tumor tracking tools.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX